Cardiovascular risk in immune-mediated inflammatory diseases
Journal of IMIDs · 2021
DOI: 10.24875/jimids.m21000004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of IMIDs, 2021. Verfasst von Carlos A. Barrera-Ochoa und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Immune-mediated inflammatory diseases (IMIDs) are a heterogeneous group of chronic diseases of unknown etiology with an inflammatory basis.They are caused by an excessive response of the immune system to various stimuli, producing chronic inflammatory lesions in different target organs with simultaneous systemic inflammation.Long-term systemic inflammation increases the risk for cardiovascular disease.Dermatologists, gastroenterologists, and rheumatologists commonly face IMIDs in their daily practice and are challenged to control the disease and provide multidisciplinary care to comorbidities and to anticipate cardiovascular outcomes.In this review, the relationship between IMIDs and cardiovascular risk is described along with the potential mechanisms that underlie these associations.Furthermore, it highlights cardiovascular disease in IMIDs patients in terms of screening and considerations for proper management.
Zitieren
APA
Barrera-Ochoa, C. A., Bern�-Rico, E., Burgos-Blasco, P., Saceda-Corralo, D., & Gonz�lez-Cantero, L. (2021). Cardiovascular risk in immune-mediated inflammatory diseases. Journal of IMIDs. https://doi.org/10.24875/jimids.m21000004
Vancouver
Barrera-Ochoa CA, Bern�-Rico E, Burgos-Blasco P, Saceda-Corralo D, Gonz�lez-Cantero L. Cardiovascular risk in immune-mediated inflammatory diseases. Journal of IMIDs. 2021. doi:10.24875/jimids.m21000004
BibTeX
@article{BarreraOchoa2021,
author = {Barrera-Ochoa, Carlos A. and Bern�-Rico, Emilio and Burgos-Blasco, Patricia and Saceda-Corralo, David and Gonz�lez-Cantero, �lvaro},
title = {Cardiovascular risk in immune-mediated inflammatory diseases},
journal = {Journal of IMIDs},
year = {2021},
doi = {10.24875/jimids.m21000004}
}
EUVIMED